Abstract
The objective of the study was to evaluate the efficacy and safety of the combined treatment with the β3 AR agonist and ROCK inhibitor in the rat model of detrusor overactivity induced by retinyl acetate instillation. The ROCK inhibitor (GSK 269962) and/or the β3 AR agonist (BRL 37344) were administered in single doses and a cystometry was carried out, along with a 24 hr measurement of cardiovascular parameters and diuresis. The combined use of GSK 269962 and BRL 37344 in doses ineffective in monotherapies, ameliorated DO. An increase was found in voided volume, voiding efficiency, volume threshold, intercontraction interval, bladder compliance, and volume threshold to elicit nonvoiding contractions, accompanied by a decrease in basal pressure, threshold pressure, detrusor overactivity index, nonvoiding contractions amplitude, and frequency. The combination therapy in question proved to have no effect on micturition voiding pressure, post-void residual, bladder contraction duration, or relaxation time. A 24 hr observation of female rats who received GSK 269962 and/or BRL 37344 did not show any significant changes in urine production. BRL 37344 increased heart rate and blood pressure proportionately to the applied dose. The asse...Continue Reading
References
Apr 1, 1994·British Journal of Clinical Pharmacology·N M WheeldonB J Lipworth
Feb 16, 1993·European Journal of Pharmacology·S TakayamaS Chiba
Jun 1, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·A J Kaumann, P Molenaar
Feb 6, 2003·British Journal of Pharmacology·C PottR H G Schwinger
Mar 19, 2003·British Journal of Pharmacology·Alexandra WibberleyTimothy D Westfall
Dec 10, 2003·Urology·Paul Abrams
Feb 9, 2006·British Journal of Pharmacology·Martin C Michel, Wim Vrydag
Jul 28, 2006·Trends in Pharmacological Sciences·Stephan L M PetersMartin C Michel
Dec 7, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Elfaridah P FrazierMartin C Michel
Feb 3, 2009·Journal of Cardiac Failure·Andreas NappWilhelm Bloch
Jun 12, 2009·The Journal of Pharmacology and Experimental Therapeutics·F Aura KullmannWilliam C de Groat
Jul 2, 2010·British Journal of Pharmacology·Jillian G Baker
Oct 6, 2010·Canadian Journal of Physiology and Pharmacology·Kajetan JuszczakPiotr J Thor
Jul 30, 2011·European Urology·Francisco CruzCornelia Haag-Molkenteller
Aug 10, 2011·Neurourology and Urodynamics·Y C ChenG D Chen
Mar 14, 2012·BJU International·Adrian WaggEmad Siddiqui
Sep 18, 2012·European Urology·Naoki AizawaYasuhiko Igawa
Nov 28, 2012·European Urology·Vik KhullarChristopher Chapple
May 10, 2015·Journal of Pharmacological and Toxicological Methods·Andrzej WróbelTomasz Rechberger
Nov 8, 2015·Neurourology and Urodynamics·Andrzej Wróbel, Tomasz Rechberger
Citations
Mar 15, 2019·Neurourology and Urodynamics·Andrzej WróbelEwa Poleszak
Apr 3, 2019·Neurourology and Urodynamics·Andrzej WróbelEwa Poleszak
Mar 11, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Andrzej WróbelEwa Poleszak
Aug 2, 2017·International Urogynecology Journal·Andrzej WróbelTomasz Rechberger
Aug 1, 2020·Frontiers in Pharmacology·Andrzej WróbelTomasz Rechberger
Feb 22, 2017·Naunyn-Schmiedeberg's Archives of Pharmacology·Andrzej WróbelPiotr Wlaź
Mar 22, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Andrzej WróbelEwa Poleszak
Jul 3, 2020·European Journal of Pharmacology·Andrzej WróbelPiotr Radziszewski